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Introduction  
High-resolution manometry (HRM) provides an intuitive and 
panoramic view of the proximal digestive physiology from the phar-
ynx to the stomach (Fig. 1). As compared to conventional manom-
etry, HRM determines more comfort and speediness to the test, 
reduces inter-observer variability, and compensates movements’ ar-
tefacts. These improvements allow a better evaluation of sphincters 
relaxation, and the identification of segmental defects of peristalsis 
not covered by the spacing of sensors in conventional systems.1,2
The more comprehensive and more appealing to the eyes 
HRM plots provoked the imagination of esophageal physiologists 
to create new investigative parameters and reclassify esophageal 
motility disorders. This led to the development of an algorithmic 
scheme for the diagnosis of esophageal motility disorders in esopha-
geal pressure topography plots, under the name of the Chicago 
classification.3 This allowed for improved recognition of motility 
disorders, and easier interpretation than conventional manometry 
line tracings.
The Chicago classification was recently revised (version 3.0) to 
exclude some previous parameters without clear clinical application, 
define parameters to be used, and classify esophageal motility disor-
ders.4 
The aim of this study was to review the Chicago classification 
version 3.0, and assess the clinical implications of the parameters 
and disorders defined by this classification.
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HRM allows the evaluation of contractility not only by am-
plitude measurement at fixed points, but through a combination 
of amplitude, time and length of the whole peristaltic wave. This 
parameter is the distal contractile integral (DCI). DCI value is cal-
culated as the product of the mean amplitude of contraction in the 
distal esophagus (mmHg) times the duration of contraction (sec-
onds), times the length of the distal esophageal segment (cm) ex-
ceeding 20 mmHg for the region spanning from the transition zone 
to the proximal aspect of the lower esophageal sphincter (LES) (Fig. 
2). DCI classifies waves as failed (DCI < 100 mmHg ∙ sec ∙ cm), 
weak (DCI 100-450 mmHg ∙ sec ∙ cm), ineffective (failed or weak), 
normal (DCI 450-8000 mmHg ∙ sec ∙ cm), or hypercontractile (DCI 
> 8000 mmHg ∙ sec ∙ cm).5 
Peristalsis 
HRM evaluates peristalsis by the distal latency (DL) which 
measures objectively the timeframe of the wave from the beginning 



















Figure 1. Normal high-resolution 
manometry plot (left) compared to the 































Figure 3. Distal latency (DL) measures objectively the time frame of 
the wave from the beginning of the swallow (upper esophageal relax-






























Figure 2. Distal contractile integral (DCI). DCI value is calculated as 
the product of the mean amplitude of contraction in the distal esopha-
gus (mmHg) times the duration of contraction (seconds) times the 
length of the distal oesophageal segment (cm) exceeding 20 mmHg 
for the region spanning from the transition zone to the proximal aspect 
of the lower esophageal sphincter.
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of the peristaltic axis known as the contractile deceleration point (Fig. 
3). Premature contractions are defined with a DL < 4.5 seconds. 
Fragmented contractions are considered segmental defects 
(break in the 20 mmHg isobaric contour > 5 cm) with normal 
contraction vigour.
Table summarizes esophageal body parameters evaluated with 
HRM. 
Lower Esophageal Sphincter
Lower esophageal sphincter pressure
The Chicago classification did not define parameters for LES 
length or basal pressure, but simply recommended assessment of 
pressure as an average of inspiratory and expiratory values for 3 
normal respiratory cycles. Relaxation, however, is measured not by 
the nadir pressure as previously done with conventional manometry, 
but with the integrated relaxation pressure (IRP) that corresponds 
























Figure 4. Integrated relaxation pressure (IRP) corresponds to the 
mean pressure of 4 seconds of greatest post deglutitive relaxation in 
a 10 seconds gap, triggered at the beginning of a swallow. Note dia-
phragmatic contraction pressure (*) during relaxation excluded from 
analysis.
Type I Type II Type III
Figure 5. Achalasia subtypes. Type I: absence of esophageal pressurization; Type II: panesophageal pressurization; Type III: premature contrac-
tions (distal latency < 4.5 seconds).
Table. Characterization of Esophageal Contractility
Contraction vigour
Failed DCI < 100 mmHg ∙ sec ∙ cm
Weak DCI 100-450 mmHg ∙ sec ∙ cm
Ineffective Failed or weak
Normal DCI 450-8000 mmHg ∙ sec ∙ cm
Hypercontractile DCI > 8000 mmHg ∙ sec ∙ cm
Contraction pattern
Premature DL < 4.5 sec
Fragmented Break > 5 cm in the 20 mmHg isobaric  
   contour with normal DCI
Intact Not achieving the above criteria
DCI, distal contractile integral; DL, distal latency.
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ation in a 10 seconds gap, triggered at the beginning of a swallow 
(Fig. 4). This metric compensates for diaphragmatic contraction 
during LES relaxation, and eliminates pseudo-relaxation due to 
movement artefacts.
Intrabolus Pressure Pattern
Abnormal intrabolus pressure corresponds to regions of 
esophageal pressurization > 30 mmHg. It may be panesophageal 
(whole esophageal body), compartmentalized (from the contractile 
deceleration point to the esophagogastric junction [EGJ]) or EGJ 
pressurization (between the LES and the diaphragm).
Esophageal Motility Disorders  
Achalasia
























Figure 7. Hypercontractile esopha-
gus (jackhammer esophagus). Distal 
contractile integral (DCI) > 8000 
mmHg ∙ sec ∙ cm in at least 20% of swal-
























Figure 8. Absent contractility. Aperistal-
sis in the setting of normal lower esoph-
ageal sphincter relaxation (integrated 
























Figure 6. Distal esophageal spasm. Premature contractions (distal 
latency [DL] < 4.5 seconds) in at least 20% of swallows.
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ation (IRP > 15 mmHg). The disease is further classified into 3 
subtypes (Fig. 5).
Type I: incomplete LES relaxation, aperistalsis and absence of 
esophageal pressurization.
Type II: incomplete LES relaxation, aperistalsis and panesoph-
ageal pressurization in at least 20% of swallows.
Type III: incomplete LES relaxation and premature contrac-
tions (DL < 4.5 seconds) in at least 20% of swal-
lows. 
Esophagogastric Junction Outflow Obstruction
EGJ obstruction is characterized by an impaired LES relax-
ation (IRP > 15 mmHg) with normal or weak peristalsis.
Major Disorders of Peristalsis
Distal esophageal spasm
Distal esophageal spasm (DES) is defined by premature con-
tractions (DL < 4.5 seconds) in at least 20% of swallows with a 
normal IRP (Fig. 6).
Hypercontractile esophagus
Hypercontractile esophagus (jackhammer esophagus) is char-
acterized by DCI > 8000 mmHg ∙ sec ∙ cm in at least 20% of swal-
lows and normal DL (Fig. 7). 
Absent contractility
Absent contractility is characterized by aperistalsis in the setting 
of normal LES relaxation (IRP < 10 mmHg) (Fig. 8).
Minor Disorders of Peristalsis
Ineffective esophageal motility






















































Figure 10. Fragmented peristalsis. ≥ 50% fragmented contractions 
with distal contractile integral (DCI) > 450 mmHg ∙ sec ∙ cm.
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swallows (failed or weak––DCI < 450 mmHg ∙ sec ∙ cm) (Fig. 9).
Fragmented peristalsis
Fragmented peristalsis is defined by ≥ 50% fragmented con-
tractions with normal contraction vigour (Fig. 10). 
Impact of High-resolution Manometry on 
the Management of Esophageal Motility 
Disorders  
The Chicago classification reclassified motility disorders previ-
ously defined by conventional manometry.6 The clinical value of this 
new classification is under scrutiny. A recent publication claims that 
the Chicago classification has a higher threshold for abnormality, 
resulting in fewer patients classified as abnormal motility.7 On the 
other hand, a recent study that randomized patients with dyspha-
gia to undergo either HRM or conventional manometry, found a 
higher proportion of manometric diagnosis in the HRM arm.8
Achalasia
The current main therapeutic options for achalasia include 
pneumatic dilatation (PD), peroral endoscopic myotomy (POEM), 
and laparoscopic Heller myotomy (LHM).9 
The Chicago classification may help to predict the result of 
treatment. Pandolfino and colleagues10 reported that type II achala-
sia patients were significantly more likely to respond to PD (91%) 
or LHM (100%), as compared to type I (56% overall) and type 
III (29% overall). Concordantly, Salvador et al11 evaluated 246 con-
secutive patients who underwent LHM and found that treatment 
failure rates were significantly different among the subtypes of acha-
lasia: type I (14.6%), type II (4.7%), and type III (30.4%) (P = 
0.0007). A recent meta-analysis encompassing 9 studies and 727 
patients also showed that type II achalasia was associated with the 
best prognosis after PD and LHM, while type III achalasia had 
the worst prognosis.12 
The Chicago classification may also help selecting the best ini-
tial approach for patients with achalasia. Kumbhari and colleagues13 
reported that in patients with type III achalasia, clinical response 
was achieved more frequently after POEM (98.0%), as compared 
to LHM (80.8%) (P = 0.01). Recently, Khashab et al14 reported 
their experience with POEM for the treatment of 54 patients 
with type III achalasia refractory to medical therapy, and showed a 
96.3% clinical success rate. Hence, while in type I and II achalasia 
both PD and LHM remain as good treatment alternatives, type III 
achalasia seems to be better managed with POEM, probably due 
to the ability to a longer myotomy of the thoracic esophagus.
Overall, sub-classification of achalasia in types I, II, and III 
with the Chicago classification seems to be useful to predict out-
comes and choose the optimal treatment approach for this motility 
disorder.
Esophagogastric Junction Outflow Obstruction
The definition of EGJ outflow obstruction based solely on 
the IRP with the exclusion of achalasia allows this diagnosis to 
be superimposed to other diagnoses dependent of the esophageal 
body motility. It may be caused by an anatomical abnormality at the 
cardia (hiatal hernia, diseases of the esophageal wall, etc) or be idio-
pathic with normal anatomy. 
Similar to achalasia, treatment is directed towards relief of the 
obstruction and can be accomplished by botulinum toxin injection, 
PD, LHM, or POEM. Both botulinum injection and PD showed 
good relief of dysphagia but with ephemeral duration.15 Scherer and 
colleagues,16 among 1000 HRM diagnosed 16 patients (1.6%) with 
EGJ outflow obstruction and treated them with botulinum toxin 
injection, PD or LHM. Only the 3 patients treated with LHM 
responded well.16 Interestingly, Pérez-Fernández et al17 reported 
that over one-third of the patients with EGJ outflow obstruction 
presented a spontaneous resolution of the symptoms, concluding 
that surgical treatment should be considered with special caution in 
these patients. In the setting of an anatomic abnormality such as a 
hiatal hernia, surgical correction is associated with long-lasting and 
excellent results.18 
EGJ outflow obstruction is now recognized as a distinct entity 
in the Chicago classification. However, the real clinical significance 
of this diagnosis is still uncertain. In fact, it could be an early or 
incomplete expression of a variant of achalasia. Thus, the exact sig-
nificance and clinical management of these patients remains unclear.
Major Disorders of Peristalsis
As the symptoms and the manometric picture of esophageal 
motility disorders can be due to gastroesophageal reflux disease 
(GERD), it is of paramount importance to rule out abnormal reflux 
by pH monitoring. If GERD is present, either medical or surgical 
treatment should be directed towards the control of the reflux.19
The management of DES remains elusive. The Chicago classi-
fication defines this disorder with a new parameter: the DL. Previ-
ous reports showed good results in patients with “diffuse esophageal 
spasm” (Richter classification)6 who underwent LHM with an 
extended myotomy.20,21 However, scarce data are available after the 
new classification defined DES. A review of the publications after 
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this definition became publicized showed that botulinum toxin 
injection in the esophageal body was superior to placebo to relieve 
dysphagia in patients with DES, and that POEM is a promising 
treatment for these patients.22 
The definition of hypercontractile esophagus (jackhammer) 
was updated in the last version of the Chicago classification to 
include only cases with ≥ 20% of swallows with a DCI > 8000 
mmHg ∙ sec ∙ cm, excluding a single altered swallow from the 
definition. Pharmacological relaxation of the smooth muscle with 
phosphodiesterase-5 inhibitor or anticholinergic agents has shown 
symptomatic improvement.23 Studies focusing on surgical therapy 
for hypercontractile esophagus based on the new classification are 
not available. Previous reports not using HRM or the Chicago 
classification, however, showed acceptable outcomes after surgical 
myotomy.24,25
Absent contractility is mostly diagnosed in patients with con-
nective tissue diseases. There is no specific treatment to restore or 
improve peristalsis in these patients. Associated GERD is usually 
the target of therapy.26
Minor Disorders of Peristalsis
Therapeutic options for ineffective esophageal motility are still 
limited, as no effective treatment is available to restore impaired 
esophageal smooth muscle contractility.27 Treatment directed to-
wards GERD is helpful when dysmotility is secondary to this dis-
ease.
The concept of fragmented peristalsis changed radically from 
previous versions to the version 3.0. Only large breaks (> 5 cm) 
with normal peristalsis are included. This is more clinically relevant, 
since incomplete bolus transit is observed in 100% of the cases of 
large breaks but only in 16% of small breaks.28 It is unclear how to 
treat this finding since there are no studies focusing on the treat-
ment for this disease under these criteria. There are no studies 
evaluating changes in the motility pattern after therapy for GERD 
as well, since both conditions are frequently associated. 
Conclusions  
HRM and the Chicago classification certainly contributed to 
a better definition of esophageal motility disorders. Particularly for 
achalasia, sub-classification in types I, II, and III seems to be useful 
to predict outcomes and choose the optimal treatment approach. 
The real clinical significance of other new parameters and disorders 
is still under investigation.
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